Acuitas Therapeutics Files Lawsuit Seeking Co-Inventor Status on Key COVID-19 Vaccine Patents

Acuitas Therapeutics is seeking recognition for its role in the development of patents tied to the COVID-19 vaccine produced in collaboration with Pfizer and BioNTech. Acuitas has filed a lawsuit in Delaware federal court arguing that its scientists should be recognized as co-inventors on several patents that Alnylam Pharmaceuticals claims were appropriated without proper acknowledgment. The core issue centers on the intellectual property used in the development of the vaccine, which has played a crucial role in the global response to the pandemic. More details can be found here.